Atom Investors LP Eliem Therapeutics, Inc. Transaction History
Atom Investors LP
- $782 Million
- Q1 2024
A detailed history of Atom Investors LP transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Atom Investors LP holds 78,276 shares of ELYM stock, worth $561,238. This represents 0.03% of its overall portfolio holdings.
Number of Shares
78,276
Previous 78,276
-0.0%
Holding current value
$561,238
Previous $211,000
1.42%
% of portfolio
0.03%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding ELYM
# of Institutions
21Shares Held
3.7MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.19MShares$15.7 Million4.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL812KShares$5.82 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$2.23 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.6KShares$477,7080.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX55.2KShares$395,9480.0% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $190M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...